Wellington Shields & Co’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Wellington Shields & Co’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$316K	Buy	+3,043	New	+$321K	0.08%	193

Other funds holding PJP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wellington Shields & Co's PJP Position: Q1 2026 in Review

Wellington Shields & Co opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q1 2026: 3,043 shares worth $316K. The stake represents 0.08% of the portfolio and ranks #193 among its holdings.

119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

Wellington Shields & Co held 3,043 shares of Invesco Pharmaceuticals ETF worth $316K as of Q1 2026.
Invesco Pharmaceuticals ETF was a new Wellington Shields & Co position in Q1 2026.
Invesco Pharmaceuticals ETF made up 0.08% of Wellington Shields & Co's portfolio in Q1 2026, its #193 holding.
119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Wellington Shields & Co's 13F filing for Q1 2026, filed 4 May 2026.